Comparison of the Effects of Albumin 5%, Hydroxyethyl Starch 130/0.4 6%, and Ringer’s Lactate on Blood Loss and Coagulation after Cardiac Surgery
We randomly assigned 240 patients undergoing elective cardiac surgery to receive up to 50 ml kg-1 day-1 of either HA, HES, or Ringer's lactate (RL) as the main infusion fluid perioperatively.
Does Tranexamic Acid Stop Haemoptysis
Current best evidence indicates that tranexamic acid may reduce both the duration and volume of bleeding, with low risk of short-term thromboembolic complications, in patients with haemoptysis.
Population Pharmacokinetics of Tranexamic Acid in Adults Undergoing Cardiac Surgery with Cardiopulmonary Bypass
The objectives of this study were to investigate the population pharmacokinetics (PK) of tranexamic acid (TA) given with either low- or high-dose continuous infusion schemes in adult cardiac surgery patients during cardiopulmonary bypass (CPB).
Comparison of Two Doses of Tranexamic Acid in Adults Undergoing Cardiac Surgery with Cardiopulmonary Bypass
The optimal dose of tranexamic acid (TA) is still an issue. The authors compared two doses of TA during cardiac surgery in a multicenter, double-blinded, randomized study.
Enhancing Intervertebral Disc Repair and Regeneration Through Biology: Platelet-Rich Plasma as an Alternative Strategy
This review describes the current understanding of intervertebral disc degeneration (IDD) and related biological therapeutic strategies, especially the promising prospects of PRP treatment.
Autologous Blood Derived Signaling Proteins for Tendon and Muscle Therapy in Sports Medicine Higher Concentration of Growth Factors and Cytokines in Orthokine VS in ACP
We compared 2 none-PRP techniques: ORTHOKINE (Oe) for Autologous Conditioned Serum (ACS) and ACP (Ax) for autologous plasma (AP)
How Effective are Injection Treatments for Lateral Epicondylitis
We compared the effectiveness, after 3 months, of a single injection of platelet-rich plasma (PRP), glucocorticoid (GC), or saline in reducing pain in lateral epicondylitis.
Prospective Clinical Trial on dosage Optimizing of Tranexamic Acid in Non-Emergency Cardiac Surgery Procedures
After withdrawal of aprotinin in 2008 only tranexamic acid (TxA, Cyclocapron, Pfitzer, Germany) remains available as antihyperfibrinolytic agent in Europe.
The Biomechanics and Histological Effects of Platelet-Rich Plasma on Fracture Healing
Platelet-rich plasma (PRP) includes growth factors and proteins that accelerate and stimulate bone regeneration and tissue recovery. The aim of this study was to evaluate the effects of PRP on fracture healing in terms of biomechanics and histology.
Comparison of Epsilon Aminocaproic Acid and Tranexamic Acid in Thoracic Aortic Surgery: Clinical Efficacy and Safety
This study evaluates the efficacy and safety of tranexamic acid (TXA) versus epsilon aminocaproic acid (EACA) in patients undergoing thoracic aortic surgery.
Impact of Smoking Status on Outcomes after Concomitant Aortic Valve Replacement and Coronary Artery Bypass Graft Surgery
There is a paucity of data on the impact of smoking status on outcomes after concomitant aortic valve replacement and coronary artery bypass graft (AVR-CABG) surgery.
Surgery in 2013 and Beyond
This paper will looks at issues and how their impact onThoracic Surgical practice in 2013 and beyond.